Blood-derived plasminogen drives brain inflammation and plaque deposition in a mouse model of Alzheimer’s disease

Guide for the Care and Use of Laboratory Animals: Eighth Edition

(2011) · doi:10.17226/12910 · Cited by 16,199 · see citing works

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

Mechanisms underlying inflammation in neurodegeneration

Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · see citing works

The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases

Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · see citing works

New tools for studying microglia in the mouse and human CNS

Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804 · see citing works

Reflex control of immunity

Tracey, K. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2566 · Cited by 1,154 · cited 1× · see citing works

Guide for the Care and Use of Laboratory Animals

Studies, D. O. E. A. L. (2011) · National Academies Press eBooks · doi:10.17226/25801 · Cited by 1,134 · see citing works

Three or more routes for leukocyte migration into the central nervous system

Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052 · see citing works

Innate immunity in Alzheimer's disease

Heneka, M. T., Golenbock, D. T., & Latz, E. (2015) · Nature Immunology · doi:10.1038/ni.3102 · Cited by 902 · see citing works

Fibrinolysis and the control of blood coagulation

Chapin, J. C., & Hajjar, K. A. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.09.003 · Cited by 842 · see citing works

Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation

Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772 · see citing works

Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor

Paresce, D. M., Ghosh, R. N., & Maxfield, F. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80187-7 · Cited by 663 · see citing works

Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain

Ramesh, G., MacLean, A. G., & Philipp, M. T. (2013) · Mediators of Inflammation · doi:10.1155/2013/480739 · Cited by 639 · see citing works

Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration

Perry, V. H., & Teeling, J. L. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0382-8 · Cited by 599 · see citing works

Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease

Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583 · see citing works

Cholinergic control of inflammation

Rosas‐Ballina, M., & Tracey, K. J. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02098.x · Cited by 582 · see citing works

Inflammatory Mechanisms in Alzheimer's Disease: Inhibition of β-Amyloid-Stimulated Proinflammatory Responses and Neurotoxicity by PPARγ Agonists

Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483 · see citing works

Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease

Yamazaki, Y., & Kanekiyo, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091965 · Cited by 451 · see citing works

Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.Preprint

Bugge, T. H., Flick, M. J., Daugherty, C. C., & Degen, J. L. (1995) · Genes & Development · doi:10.1101/gad.9.7.794 · Cited by 437 · see citing works

TMEM119 marks a subset of microglia in the human brain

Satoh, J., Kino, Y., Asahina, N., Takitani, M., Miyoshi, J., Ishida, T., & Saito, Y. (2016) · Neuropathology · doi:10.1111/neup.12235 · Cited by 434 · see citing works

Microglia and Inflammation in Alzheimers Disease

Mandrekar-Colucci, S., & Landreth, G. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012071 · Cited by 421 · see citing works

A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain

Ryu, J. K., & McLarnon, J. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00434.x · Cited by 406 · see citing works

Inflammation and Alzheimer’s disease

Lee, Y.-J., Han, S. B., Nam, S.-Y., Oh, K.-W., & Hong, J. T. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1006-7 · Cited by 396 · see citing works

Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors

Salminen, A., Ojala, J. O., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.001 · Cited by 350 · see citing works

Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice

Gong, Y., Hart, E., Shchurin, A., & Hoover-Plow, J. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32750 · Cited by 334 · see citing works

Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease

Paul, J., Strickland, S., & Melchor, J. P. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070304 · Cited by 319 · see citing works

The Plasmin System Is Induced by and Degrades Amyloid-β Aggregates

Tucker, H. M., Kihiko‐Ehmann, M., Caldwell, J. N., Wright, S., Kawarabayashi, T., PRICE, D. A., Walker, D., Scheff, S. W., McGillis, J. P., Rydel, R. E., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-03937.2000 · Cited by 306 · see citing works

Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders

Hong, H., Kim, B. S., & Im, H. (2016) · International Neurourology Journal · doi:10.5213/inj.1632604.302 · Cited by 260 · see citing works

A PLASMIN-SPLIT FRAGMENT OF C'3 AS A NEW CHEMOTACTIC FACTOR

Ward, P. A. (1967) · The Journal of Experimental Medicine · doi:10.1084/jem.126.2.189 · Cited by 257 · see citing works

Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulation

Maas, C., Govers‐Riemslag, J. W. P., Bouma, B., Schiks, B., Hazenberg, B. P. C., Lokhorst, H. M., Hammarström, P., Cate, H. T., de Groot, P. G., Bouma, B. N., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35424 · Cited by 243 · see citing works

The Neurology of the Immune System: Neural Reflexes Regulate Immunity

Rosas‐Ballina, M., & Tracey, K. J. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.039 · Cited by 226 · see citing works

Activation of plasminogen by human plasma kallikrein

Colman, R. W. (1969) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(69)90278-2 · Cited by 219 · see citing works

Brain plasmin enhances APP α‐cleavage and Aβ degradation and is reduced in Alzheimer's disease brains

Ledesma, M. D., Silva, J. S. D., Craessaerts, K., Delacourte, A., Strooper, B. D., & Dotti, C. G. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd107 · Cited by 216 · see citing works

Plasmin as a proinflammatory cell activator

Syrovets, T., Lunov, O., & Simmet, T. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212056 · Cited by 215 · see citing works

The immunology of neurodegeneration

Czirr, E., & Wyss‐Coray, T. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58656 · Cited by 211 · see citing works

Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain

Galea, I., Palin, K., Newman, T. A., van Rooijen, N., Perry, V. H., & Boche, D. (2004) · Glia · doi:10.1002/glia.20124 · Cited by 183 · see citing works

Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease

Landel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., & Féron, F. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-33 · Cited by 176 · see citing works

Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations

de Maat, S., Björkqvist, J., Suffritti, C., Wiesenekker, C. P., Nagtegaal, W., Koekman, A. C., van Dooremalen, S., Pasterkamp, G., de Groot, P. G., Cicardi, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.02.021 · Cited by 170 · see citing works

Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a.

Williams, T. J., & Jose, P. J. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.153.1.136 · Cited by 160 · see citing works

Novel aspects and new roles for the serine protease plasmin

Syrovets, T., & Simmet, T. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3348-5 · Cited by 156 · see citing works

Role of the Contact System in Fibrinolysis

Kluft, C., Dooijewaard, G., & EMEIS, J. J. (1987) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1003475 · Cited by 149 · see citing works

The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1

Teeling, J. L., Cunningham, C., Newman, T. A., & Perry, V. H. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.11.006 · Cited by 139 · see citing works

Pathogenic Mechanisms of Bradykinin Mediated Diseases

Kaplan, A. P., & Joseph, K. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00002-7 · Cited by 127 · see citing works

Plasmin-Mediated Activation of Contact System in Response to Pharmacological Thrombolysis

Ewald, G. A., & Eisenberg, P. R. (1995) · Circulation · doi:10.1161/01.cir.91.1.28 · Cited by 118 · see citing works

Tissue Plasminogen Activator Requires Plasminogen to Modulate Amyloid‐β Neurotoxicity and Deposition

Tucker, H. M., Kihiko‐Ehmann, M., Wright, S., Rydel, R. E., & Estus, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752172.x · Cited by 113 · see citing works

Plasmin Cleavage of the Amyloid β-Protein: Alteration of Secondary Structure and Stimulation of Tissue Plasminogen Activator Activity

Nostrand, W. E. V., & Porter, M. D. (1999) · Biochemistry · doi:10.1021/bi990610f · Cited by 113 · see citing works

Activation of the factor XII-driven contact system in Alzheimer’s disease patient and mouse model plasma

Zamolodchikov, D., Chen, Z., Conti, B. A., Renné, T., & Strickland, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423764112 · Cited by 109 · see citing works

Plasminogen activator/plasmin system: A major player in wound healing?

Li, W., Chong, S., Huang, E. Y., & Tuan, T. (2003) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2003.11402.x · Cited by 109 · see citing works

Plasmin Is a Potent and Specific Chemoattractant for Human Peripheral Monocytes Acting Via a Cyclic Guanosine Monophosphate–Dependent Pathway

Syrovets, T., Tippler, B. G., Rieks, M., & Simmet, T. (1997) · Blood · doi:10.1182/blood.v89.12.4574 · Cited by 102 · see citing works

Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease

Liu, R., Groen, T. V., Katre, A. K., Cao, D., Kadisha, I., Ballinger, C. A., Wang, L., Carroll, S. L., & Li, L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.003 · Cited by 95 · see citing works

Regulation of macrophage migration by a novel plasminogen receptor Plg-RKT

Lighvani, S., Baik, N., Diggs, J. E., Khaldoyanidi, S. K., Parmer, R. J., & Miles, L. A. (2011) · Blood · doi:10.1182/blood-2011-03-344242 · Cited by 95 · see citing works

Plasminogen promotes macrophage phagocytosis in mice

Das, R., Ganapathy, S., Settle, M., & Plow, E. F. (2014) · Blood · doi:10.1182/blood-2014-01-549659 · Cited by 92 · see citing works

Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen

Mandle, R. J., & Kaplan, A. P. (1979) · Blood · doi:10.1182/blood.v54.4.850.850 · Cited by 90 · see citing works

Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice

Chen, Z., Revenko, A. S., Singh, P. K., MacLeod, A. R., Norris, E. H., & Strickland, S. (2017) · Blood · doi:10.1182/blood-2016-11-753202 · Cited by 85 · see citing works

The plasminogen activation system in neuroinflammation

Mehra, A., Ali, C., Parcq, J., Vivien, D., & Docagne, F. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.011 · Cited by 81 · see citing works

The Plasminogen Activator/Plasmin System Is Essential for Development of the Joint Inflammatory Phase of Collagen Type II-Induced Arthritis

Li, J., Ny, A., Leonardsson, G., Nandakumar, K. S., Holmdahl, R., & Ny, T. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62299-7 · Cited by 78 · see citing works

Breaking boundaries—coagulation and fibrinolysis at the neurovascular interface

Bardehle, S., Rafalski, V. A., & Akassoglou, K. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00354 · Cited by 76 · see citing works

Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++.

Lepow, I. H., Wurz, L., Ratnoff, O. D., & Pillemer, L. (1954) · PubMed · Cited by 74 · see citing works

Activation of the Contact System in Cerebrospinal Fluid of Patients with Alzheimer Disease

Bergamaschini, L. C., Parnetti, L., Pareyson, D., Canziani, S., Cugno, M., & Agostoni, A. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199806000-00008 · Cited by 65 · see citing works

Activation of complement and contact system in Alzheimer's disease

Bergamaschini, L. C., Donarini, C., Gobbo, G. F. D., Parnetti, L., & Gallai, V. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00311-6 · Cited by 54 · see citing works

Studies on the Mechanism of Inactivation of Human Complement by Plasmin and by Antigen-Antibody Aggregates

Lepow, I. H., Wurz, L., Ratnoff, O. D., & Pillemer, L. (1954) · The Journal of Immunology · doi:10.4049/jimmunol.73.3.146 · Cited by 54 · see citing works

Genetically Modified CD34+ Hematopoietic Stem Cells Contribute to Turnover of Brain Perivascular Macrophages in Long-Term Repopulated Primates

Soulas, C., Donahue, R. E., Dunbar, C. E., Persons, D. A., Alvarez, X. A., & Williams, K. C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081010 · Cited by 52 · see citing works

A Tale of Two Genes: Microglial Apoe and Trem2

Pimenova, A. A., Marcora, E. M., & Goate, A. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.015 · Cited by 52 · see citing works

Role of thrombin in the pathogenesis of central nervous system inflammatory diseases

Ebrahimi, S., Jaberi, N., Avan, A., Ryzhikov, M., Keramati, M. R., Parizadeh, M. R., & Hassanian, S. M. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25501 · Cited by 44 · see citing works

Factor XIIa Is a Kinetically Favorable Plasminogen Activator

Feddersen, K., Røjkjær, R., & Schousboe, I. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614326 · Cited by 43 · see citing works

Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndrome

Shimazu, H., Munakata, S., Tashiro, Y., Salama, Y., Dhahri, D., Eiamboonsert, S., Ota, Y., Onoda, H., Tsuda, Y., Okada, Y., et al. (2017) · Blood · doi:10.1182/blood-2016-09-738096 · Cited by 42 · see citing works

Inhibition of Plasmin Activity by Tranexamic Acid Does Not Influence Inflammatory Pathways During Human Endotoxemia

Renckens, R., Weijer, S., de Vos, A. F., Pater, J. M., Meijers, J. C. M., Hack, C. E., Levi, M. M., & van der Poll, T. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118280.95422.48 · Cited by 41 · see citing works

Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer׳s disease

Oh, S. B., Suh, N., Kim, I., & Lee, J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.042 · Cited by 38 · see citing works

Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease

Shaw, M. A., Gao, Z., McElhinney, K. E., Thornton, S., Flick, M. J., Lane, A., Degen, J. L., Ryu, J. K., Akassoglou, K., & Mullins, E. S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2932-15.2017 · Cited by 38 · see citing works

Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain

Hultman, K., Cortés‐Canteli, M., Bounoutas, A., Richards, A. T., Strickland, S., & Norris, E. H. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12553 · Cited by 36 · see citing works

Plasmin cleaves Aβ42 in vitro and prevents its aggregation into β-pleated sheet structures

Exley, C., & Korchazhkina, O. V. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00042 · Cited by 33 · see citing works

Limited proteolysis of C5b-6: functional stability of the degraded complex.

Podack, E. R., & Müller‐Eberhard, H. J. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.1.332 · Cited by 29 · see citing works

An Overview of Hemostasis

Ogedegbe, H. O. (2002) · Laboratory Medicine · doi:10.1309/50uq-gupf-w6xw-1x7b · Cited by 25 · see citing works

Exerkines in health, resilience and disease

Chow, L. S., Gerszten, R. E., Taylor, J. M., Pedersen, B. K., van Praag, H., Trappe, S., Febbraio, M. A., Galis, Z. S., Gao, Y., Haus, J. M., et al. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00641-2 · Cited by 927 · see citing works

Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain

Horowitz, A. M., Fan, X., Bieri, G., Smith, L. K., Sanchez-Diaz, C. I., Schroer, A. B., Gontier, G., Casaletto, K. B., Kramer, J. H., Williams, K. E., et al. (2020) · Science · doi:10.1126/science.aaw2622 · Cited by 496 · see citing works

Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies

Han, L., & Jiang, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.023 · Cited by 358 · see citing works

Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia

Hussain, B., Fang, C., & Chang, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.688090 · Cited by 251 · see citing works

Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances

Niu, X.-Q., Chen, J.-J., & Gao, J.-Q. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2018.09.005 · Cited by 161 · see citing works

Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives

Fisher, R. A., Miners, J. S., & Love, S. (2022) · Brain Pathology · doi:10.1111/bpa.13061 · Cited by 127 · see citing works

A critical role for plasminogen in inflammation

Baker, S. K., & Strickland, S. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191865 · Cited by 125 · see citing works

An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s disease

Clark, C., Dayon, L., Masoodi, M., Bowman, G. L., & Popp, J. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00814-7 · Cited by 116 · see citing works

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

Mongan, D., Föcking, M., Healy, C., Susai, S. R., Heurich, M., Wynne, K. J., Nelson, B., McGorry, P. D., Amminger, G. P., Nordentoft, M., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.2459 · Cited by 102 · see citing works

Liraglutide Protects Against Brain Amyloid-β1–42 Accumulation in Female Mice with Early Alzheimer’s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation

Duarte, A. I., Candeias, E., Alves, I. N., Mena, D., da Silva, D. F., Machado, N. J., Campos, E. J., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051746 · Cited by 90 · see citing works

Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management

Ellis, R. J., Marquine, M. J., Kaul, M., Fields, J. A., & Schlachetzki, J. C. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00879-y · Cited by 98 · see citing works

Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm

Grabowska, W., Want, A., Leszek, J., & Wojda, U. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103691 · Cited by 79 · see citing works

Serpin Signatures in Prion and Alzheimer’s Diseases

Zattoni, M., Mearelli, M., Vanni, S., Baldeschi, A. C., Tran, T. H., Ferracin, C., Catania, M., Moda, F., Fede, G. D., Giaccone, G., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02817-3 · Cited by 74 · see citing works

Infection-Induced Systemic Inflammation Is a Potential Driver of Alzheimer's Disease Progression

Giridharan, V. V., Masud, F. N., Petronilho, F. C., Dal‐Pizzol, F., & Barichello, T. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00122 · Cited by 67 · see citing works

Influenza vaccination in early Alzheimer’s disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells

Yang, Y., He, Z., Xing, Z., Zuo, Z., Yuan, L., Wu, Y., Jiang, M. H., Qi, F., & Yao, Z. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01741-4 · Cited by 67 · see citing works

Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study

Juneja, G. K., Castelo, M., Yeh, C. H., Cerroni, S. E., Hansen, B. E., Chessum, J. E., Abraham, J., Cani, E., Dwivedi, D. J., Fraser, D. D., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15327 · Cited by 63 · see citing works

Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease

Singh, S., Saleem, S., & Reed, G. L. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.608899 · Cited by 61 · see citing works

Glucose metabolism: A link between traumatic brain injury and Alzheimer’s disease

Xu, X., Yang, M.-S., Zhang, B., Niu, F., Dong, J., & Liu, B. (2020) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2020.10.001 · Cited by 59 · see citing works

Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer's patients

Singh, P. K., Chen, Z., Ghosh, D., Strickland, S., & Norris, E. H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104833 · Cited by 57 · see citing works

Plasminflammation—An Emerging Pathway to Bradykinin Production

Maas, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02046 · Cited by 52 · see citing works

Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases

Wieczorek, E., & Ożyhar, A. (2021) · Cells · doi:10.3390/cells10071768 · Cited by 49 · see citing works

Aging Neurovascular Unit and Potential Role of DNA Damage and Repair in Combating Vascular and Neurodegenerative Disorders

Li, Y., Xie, L., Huang, T., Zhang, Y., Zhou, J., Qi, B., Wang, X., Chen, Z., & Li, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00778 · Cited by 46 · see citing works

Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children

Madrid-Gambín, F., Föcking, M., Sabherwal, S., Heurich, M., English, J. A., O’Gorman, A., Suvitaival, T., Ahonen, L. L., Cannon, M. D., Lewis, G., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.01.018 · Cited by 43 · see citing works

Pathophysiological Role of Microglial Activation Induced by Blood-Borne Proteins in Alzheimer’s Disease

Kim, S., Sharma, C., Jung, U. J., & Kim, S. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051383 · Cited by 40 · see citing works

The dark side of Alzheimer’s disease: unstructured biology of proteins from the amyloid cascade signaling pathway

Gadhave, K., Gehi, B. R., Kumar, P., Xue, B., Uversky, V. N., & Giri, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03414-9 · Cited by 33 · see citing works

Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines

Pontecorvi, P., Banki, M. A., Zampieri, C., Zalfa, C., Azmoon, P., Kounnas, M., Marchese, C., Gonias, S., & Mantuano, E. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1657-3 · Cited by 27 · see citing works

NLRC3 Delays the Progression of AD in APP/PS1 Mice via Inhibiting PI3K Activation

Zha, L., Yu, Z., Fang, J., Zhou, L., Guo, W., & Zhou, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5328031 · Cited by 30 · see citing works

Plasminogen Activators in Neurovascular and Neurodegenerative Disorders

Yepes, M., Woo, Y., & Martín-Jiménez, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094380 · Cited by 28 · see citing works

Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective

Ashique, S., Afzal, O., Yasmin, S., Hussain, A., Altamimi, M. A., Webster, T. J., & Altamimi, A. S. A. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122614 · Cited by 28 · see citing works

Functions of the plasminogen receptor Plg‐RKT

Miles, L. A., Vago, J. P., Sousa, L. P., & Parmer, R. J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15014 · Cited by 27 · see citing works

Biomimetic engineering of a neuroinflammation-targeted MOF nanozyme scaffolded with photo-trigger released CO for the treatment of Alzheimer's disease

Liu, C., Zhang, W., Zhang, H., Zhao, C., Du, X., Ren, J., & Qu, X. (2024) · Chemical Science · doi:10.1039/d4sc02598a · Cited by 26 · see citing works

Anticoagulants for Treatment of Alzheimer’s Disease

Grossmann, K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200610 · Cited by 25 · see citing works

Integration of transcriptomics and network analysis deciphers the mechanisms of baicalein in improving learning and memory impairment in senescence-accelerated mouse prone 8 (SAMP8)

Li, J., Zhou, Y., Du, G., Qin, X., & Gao, L. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172789 · Cited by 22 · see citing works

Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction

VanDusen, K. W., Li, Y., Cai, V., Hall, A., Hiles, S., Thompson, J. W., Moseley, M. A., Cooter, M. L., Acker, L., Levy, J. H., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201544 · Cited by 21 · see citing works

Proteomics of human platelet lysates and insight from animal studies on platelet protein diffusion to hippocampus upon intranasal administration

Le, N. T. N., Han, C., Delila, L., Nebie, O., Chien, H.-T., Wu, Y., Buée, L., Blum, D. L., & Burnouf, T. P. R. (2024) · APL Bioengineering · doi:10.1063/5.0196553 · Cited by 21 · see citing works

Vascular Dysfunction in Alzheimer’s Disease: Alterations in the Plasma Contact and Fibrinolytic Systems

Badimon, A., Torrente, D., & Norris, E. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087046 · Cited by 21 · see citing works

Antisense therapy: a potential breakthrough in the treatment of neurodegenerative diseases

Romanò, R., & Bucci, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385285 · Cited by 20 · see citing works

Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran

Grossmann, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094805 · Cited by 19 · see citing works

Nrf2 activator PB125® as a carnosic acid-based therapeutic agent against respiratory viral diseases, including COVID-19

McCord, J. M., Hybertson, B. M., Cota‐Gomez, A., & Gao, B. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.033 · Cited by 17 · see citing works

Immune-metabolic mechanisms of post-traumatic stress disorder and atherosclerosis

Tian, Y., Ullah, H., Gu, J., & Li, K. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1123692 · Cited by 18 · see citing works

Identification of Plasma Proteins as Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease Using Liquid Chromatography–Tandem Mass Spectrometry

Inoue, M., Suzuki, H., Meno, K., Liu, S., Korenaga, T., & Uchida, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713064 · Cited by 17 · see citing works

Change in the plasma proteome associated with canine cognitive dysfunction syndrome (CCDS) in Thailand

Phochantachinda, S., Chantong, B., Reamtong, O., & Chatchaisak, D. (2021) · BMC Veterinary Research · doi:10.1186/s12917-021-02744-w · Cited by 15 · see citing works

Plasminogen mediates communication between the peripheral and central immune systems during systemic immune challenge with lipopolysaccharide

Baker, S. K., Chen, Z., Norris, E. H., & Strickland, S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1560-y · Cited by 15 · see citing works

Cerebrospinal Fluid Proteomic Profiles in Patients with Postherpetic Neuralgia

Chen, K., Wang, M., Long, D., Zou, D., Li, X., Wang, R., Wang, Y., & Yang, L. C. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00547 · Cited by 13 · see citing works

Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression

Chowdhury, N. N., Yang, Y., Dutta, A., Luo, M., Wei, Z., Abrahams, S. R., Revenko, A. S., Shah, F., Miles, L. A., Parmer, R. J., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13552 · Cited by 12 · see citing works

REMOVED: Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide

Sharma, H. S., Muresanu, D. F., Nozari, A., Lafuente, J. V., Buzoianu, A. D., Sahib, S., Tian, Z. R., Bryukhovetskiy, I., Manzhulo, I., Menon, P. K., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.04.008 · Cited by 11 · see citing works

Oligonucleotides: A novel area of interest for drug delivery in neurodegenerative diseases

Alharbi, K. S., Shaikh, M. A. J., Afzal, O., Altamimi, A. S. A., Almalki, W. H., Kazmi, I. A., Al-Abbasi, F. A., Alzarea, S. I., Babu, M. R., Singh, S. K., et al. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103849 · Cited by 8 · see citing works

RNA therapeutics to control fibrinolysis: review on applications in biology and medicine

Ferraresso, F., Leung, J., & Kastrup, C. J. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.04.006 · Cited by 6 · see citing works

pKr-2 induces neurodegeneration via upregulation of microglial TLR4 in the hippocampus of AD brain

Kim, S., Sharma, C., Shin, M., Kim, H., Kim, J., & Kim, S. R. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100593 · Cited by 5 · see citing works

‘Machine Learning’ multiclassification for stage diagnosis of Alzheimer’s disease utilizing augmented blood gene expression and feature fusion

Sarma, M., & Chatterjee, S. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07237-1 · Cited by 4 · see citing works

Potential link of high fat diet and mRNA expression of Alzheimer's disease-related genes in the enteric mucosa of a rat model of Alzheimer's disease

Gokulan, K., Karn, K., Sarkar, S., Raymick, J. B., & Khare, S. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251358414 · Cited by 3 · see citing works

A systematic review on application of nano-carriers loaded with drug in the treatment of neurological disorders

Shaikh, A. A., Anbhule, S. J., & Raykar, M. H. (2023) · Current Trends in Pharmacy and Pharmaceutical Chemistry · doi:10.18231/j.ctppc.2023.012 · Cited by 3 · see citing works

Аmygdala DEGs are associated with the immune system function: A comparative transcriptomic study of high- and low-excitability rat strains

Геннадьевна, Ш. И., Pavlova, M. B., & Dyuzhikova, N. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323325 · Cited by 3 · see citing works

Recent advances in patented inhibitors targeting serine proteases in inflammatory diseases

Soualmia, F., Carvaillo, H., Boumali, R., Masurier, N., & Amri, C. E. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118260 · Cited by 2 · see citing works

Liver-brain axis mechanism underlying central immune remodeling triggered by peripheral hepatic damage

Tian, X., Ren, Y., Chen, Y., 程相树, & Wei, J. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112626 · Cited by 2 · see citing works

The Double-Edged Sword Effect of the Fibrinolytic System in Alzheimer’s Disease

Tang, M., Liang, M., Zhang, X., Hong, C., & Ye, L. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01699-6 · Cited by 1 · see citing works

Hepatocyte tPA: where have you been hiding?

Gonias, S. L. (2019) · Blood · doi:10.1182/blood-2018-12-891515 · Cited by 1 · see citing works

Roles of plasminogen activator-plasmin system in nerve system: from physiology to pathology

Kawashita, E. (2020) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.31.381

Additional file 2 of Change in the plasma proteome associated with canine cognitive dysfunction syndrome (CCDS) in Thailand

Phochantachinda, S., Chantong, B., Reamtong, O., & Chatchaisak, D. (2021) · Figshare · doi:10.6084/m9.figshare.13668053

Additional file 1 of An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s disease

Clark, C., Dayon, L., Masoodi, M., Bowman, G. L., & Popp, J. (2021) · Figshare · doi:10.6084/m9.figshare.14361431

Additional file 3 of An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s disease

Clark, C., Dayon, L., Masoodi, M., Bowman, G. L., & Popp, J. (2021) · Figshare · doi:10.6084/m9.figshare.14361437

Additional file 1 of Change in the plasma proteome associated with canine cognitive dysfunction syndrome (CCDS) in Thailand

Phochantachinda, S., Chantong, B., Reamtong, O., & Chatchaisak, D. (2021) · Figshare · doi:10.6084/m9.figshare.13668050

Additional file 4 of Change in the plasma proteome associated with canine cognitive dysfunction syndrome (CCDS) in Thailand

Phochantachinda, S., Chantong, B., Reamtong, O., & Chatchaisak, D. (2021) · Figshare · doi:10.6084/m9.figshare.13668059

Additional file 2 of An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s disease

Clark, C., Dayon, L., Masoodi, M., Bowman, G. L., & Popp, J. (2021) · Figshare · doi:10.6084/m9.figshare.14361434

Iron Oxide Nanoparticles as Potential Nano-Based Neurotherapeutic Agents for Neurodegenerative Disorders

Fouad, G. I., Aly, H. F., & Rizk, M. Z. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-4627-4.ch004

Vascular and synaptic proteomes reveal blood-brain barrier disruption and postsynaptic remodeling in human temporal lobe epilepsyPreprint

Spillard, G., Zhang, M., Atai, N. A., Bosworth, A., Clementel, V. A., Russin, J. J., Liu, C. Y., Coba, M. P., & Rust, R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.11.731740 · Cited by 1 · see citing works

Rather a versatile multi-tool than a sword: an integral role of the plasminogen system in health and disease

Škrabana, R., Castven, M., Tomková, M., Sedlák, E., Babulic, P., Jakubcova, M., Moskalets, T., & Leksa, V. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1878106

Blood-Derived Plasminogen Modulates the Neuroimmune Response in Both Alzheimer's Disease and Systemic Infection Models

Baker, S. K. (2025) · Digital Commons - RU (Rockefeller University) · doi:10.48496/jxem-0c74

Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer’s disease

Tang, M.-Y., Gorin, F. A., & Lein, P. J. (2022) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.05 · Cited by 20 · see citing works

Plasminogen and plasmin in Alzheimer's disease

Barker, R. M., Love, S., & Kehoe, P. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.025 · Cited by 41 · see citing works

Activators and inhibitors of the plasminogen system in Alzheimer’s disease

Barker, R. M., Kehoe, P. G., & Love, S. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01394.x · Cited by 49 · see citing works

P1‐409: Knockdown of plasminogen activator inhibitor 1 gene reduces cerebral amyloid‐beta peptide burden in a mouse model of Alzheimer's disease

Liu, R.-M., van Groen, T., Kadish, I., Li, L., Katre, A. K., Hu, K., & Li, J. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.991 · Cited by 2 · see citing works